Rapid, Selective, and Rugged Method Development and Validation of Atorvastatin and its Active Metabolites, o-Hydroxy Atorvastatin and p-Hydroxy Atorvastatin, in Stabilized Plasma Using Liquid Chromatography Coupled with Tandem Mass Spectrometry

References

• Lennernas, H. Clinical Pharmacokinetics of Atorvastatin. Clin. Pharmacokinet. 2003, 42, 1141–1160.
   PubMed Web of Science ®Google Scholar
• Poli, A. Atorvastatin: Pharmacological Characteristics and Lipid Lowering Effects. Drugs 2007, 67, 3–15.
   PubMed Web of Science ®Google Scholar
• Kearney, A. S.; Crawford, L. F.; Mehta, S. C. The Interconversion Kinetics, Equilibrium, and Solubilities of the Lactone and Hydroxyacid Forms of the HMG CoA Reductase Inhibitor, CT-981. Pharm. Res. 1993, 10, 1461–1465.
   PubMed Web of Science ®Google Scholar
• CillaJr., D. D.; Whitifield, L. R.; Gibson, D. M. Multiple Dose Pharmacokinetics, Pharmacodynamics, and Safety of Atorvastatin, an Inhibitor of HMG CoA Reductase, in Healthy Subjects. Clin. Pharmacol. Ther. 1996, 60, 828–847.
   Web of Science ®Google Scholar
• Lea, A. P.; McTavish, D. Atorvastatin. A Review of Its Pharmacology and Therapeutic Potential in the Management of Hyperlipidaemias. Drugs 1997, 53, 828–847.
   PubMed Web of Science ®Google Scholar
• Igel, M.; Sudhlop, T.; Von Bergmann, K. Pharmacology of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors (Statins), Including Rosuvastatin and Pitavastatin. J. Clin. Pharmacol. 2002, 42, 835–845.
   PubMed Web of Science ®Google Scholar
• Black, A. E.; Hayes, R. N.; Roth, B. D. Metabolism and Excretion of Atrovastatin in Rats and Dogs. Drug Metb. Dispos. 1999, 27, 916–923.
   PubMed Web of Science ®Google Scholar
• Posavar, E. L.; Radulovic, L. L.; Cilla Jr., D. D. Tolerance and Pharmacokinetics of Single Atorvastatin, A Potent Inhibitor of HMG CoA Reductase, in Healthy Subjects. J. Clin. Pharmacol. 1996, 36, 728–731.
   PubMed Web of Science ®Google Scholar
• Siedlik, P. H.; Olson, S. C.; Yang, B. B. Erythromycin Coadministration Increases Plasma Atorvastatin Levels. J. Clin. Pharmacol. 1999, 39, 501–504.
   PubMed Web of Science ®Google Scholar
• Bahrami, G.; Mohammadi, B.; Mirzaeei, S. Determination of Atorvastatin in Human Serum by Reversed Phase High Performance Liquid Chromatography with UV Detection. J. Chromatogr. B. 2005, 826, 41–45.
   PubMed Web of Science ®Google Scholar
• Zarghi, A.; Shafaati, A.; Foroutan, S. M. A Simple and Rapid HPLC Method for the Determination of Atorvastatin in Human Plasma with UV Detection and Its Application and Its Application to Pharmacokinetics Studies. Arzneimittelforschung. 2005, 55, 451–454.
   PubMed Web of Science ®Google Scholar
• Gibson, D. M.; Stern, R.; Abel, R. B. Absolute Bioavailability of Atorvastatin in Man. Pharm. Res. 1997, 14, S253.
   Google Scholar
• Ma, L.; Dong, J.; Chen, X. J. Development and Validation of Atorvastatin by LC-ESI-MS and Application in Bioequivalence Research in Healthy Chinese Volunteers. Chromatographia. 2007, 65, 737–741.
   Web of Science ®Google Scholar
• Bullen, W. W.; Miller, R. A.; Hayes, R. N. Development and Validation of High Performance Liquid Chromatography Tandem Mass Spectrometry Assay for Atorvastatin, ortho-hydroxy Atorvastatin, and para-Hydroxy Atorvastatin in Human, Dog, and Rat Plasma. J. Am. Soc. Mass Spectrum. 1999, 10, 1003–1015.
   Web of Science ®Google Scholar
• Jemal, M.; Ouyang, Z.; Chen, B. C. Quantitation of the Acid and Lactone Forms of Atorvastatin and Its Biotransformation Products in Human Serum by High Performance Liquid Chromatography with Electrospray Tandem Mass Spectrometry. Rapid Commun. Mass Spectrum. 1999, 13, 1003–1015.
   PubMed Web of Science ®Google Scholar
• Hermann, M.; Chirstensen, H.; Reubsaet, J. L. Determination of Atorvastatin and Its Metabolites in Human Plasma with Solid-phase Exraction Followed by LC-tandem MS. Anal. Bioanal. Chem. 2006, 385, 275–285.
   Google Scholar
• Borek-Dohalsky, V.; Huclova, J.; Barrett, B. Validated HPLC-MS-MS Method for Simultaneous Determination of Atorvastatin and 2-Hydroxy Atorvastatin in Human Plasma-Pharmacokinetic Study. Anal. Bioanal. Chem. 2006, 386, 275–285.
   PubMed Web of Science ®Google Scholar
• Nirogi, R. V.; Kandikere, V. N.; Shukla, M. Simultaneous Quantification of Atorvastatin and Active Metabolites in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry Using Rosuvastatin as Internal Standard. Biomed. Chromatogr. 2006, 20, 924–936.
   PubMed Web of Science ®Google Scholar
• Liu, D.; Jiang, J.; Zhou, H. Quantitative Determination of Atorvastatin and para-hydroxy Atorvastatin in Human Plasma by LC-MS-MS. J. Chromatogr. Sci. 2008, 46, 862–866.
   PubMed Web of Science ®Google Scholar
• Guilen, D.; Jiang, J.; Zhou, H. Determination of Atorvastatin and Its Metabolite ortho-Hydroxy Atorvastatin in Human Plasma by On-line Anion Exchange Solid Phase Extraction and Liquid Chromatography Tandem Mass Spectrometry. Anal. Biomed. Chem. 2009, 394, 1687–1696.
   PubMed Web of Science ®Google Scholar
• Novakova, L.; Vlckova, H.; Satinsky, D. Ultra High Performance Liquid Chromatography Tandem Mass Spectrometric Detection in Clinical Analysis of Simvastatin and Atrovastatin. J. Achromatogr. B. 2009, 877, 2093–2013.
   PubMed Web of Science ®Google Scholar
• Macwan, J. S.; Ionita, I. A.; Dostalek, M. Development and Validation of a Sensitive, Simple, and Rapid Method for Simultaneous Quantification of Atorvastatin and Its Metabolites by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Anal. Bioanal. Chem. 2011, 400, 423–433
   PubMed Web of Science ®Google Scholar
• Partani, P.; Verma, S. M.; Gurule, S.; Khuroo, A.; Monif, T. Simultaneous Quantitation of Atorvastatin and Its Two Active Metabolites in Human Plasma by Liquid Chromatography/(−) Electrospray Tandem Mass Spectrometry. J. Pharm. Anal. 2014, 26–36.
   Google Scholar
• Synder, L. R.; Kirland, J. J. Practical HPLC Method Development, 2nd ed.; Hoboken, NJ, USA; 2000.
   Google Scholar